Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma-Reference-Cited by-同舟云学术

Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma

Published:2023-08 Issue: Volume:570 Page:216329
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

De Martino Mara,Daviaud Camille,Minns Hanna E.,Lazarian Artur,Wacker Anja,Costa Ana Paula,Attarwala Nabeel,Chen Qiuying,Choi Seung-Won,Rabadàn Raùl,McIntire Laura Beth J.,Gartrell Robyn D.,Kelly James M.^ORCID,Laiakis Evagelia C.,Vanpouille-Box Claire^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Rising incidence of glioblastoma multiforme in a well-defined population;Grech;Cureus,2020

2. Brain tumours: rise in glioblastoma multiforme incidence in england 1995-2015 suggests an adverse environmental or lifestyle factor;Philips;J Environ Public Health,2018

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

4. Radiation therapy for glioblastoma: American society of clinical Oncology clinical practice guideline endorsement of the American society for radiation Oncology guideline;Sulman;J. Clin. Oncol.,2017

5. Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy;Beauchesne;Neuro Oncol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management;Cancer Letters;2024-10

2. Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases;Cancer Letters;2024-08

3. Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models;Cancers;2024-07-24

4. COX2-dependent suppression of anticancer immunity;Trends in Cancer;2024-07

5. BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine;Cancer Letters;2024-06